Doximity (NASDAQ:DOCS) PT Raised to $27.00 at Wells Fargo & Company

Doximity (NASDAQ:DOCSGet Free Report) had its target price hoisted by investment analysts at Wells Fargo & Company from $25.00 to $27.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential downside of 5.40% from the company’s previous close.

A number of other brokerages have also commented on DOCS. Barclays started coverage on Doximity in a report on Wednesday, January 3rd. They set an “equal weight” rating and a $31.00 price objective for the company. Morgan Stanley boosted their price objective on Doximity from $21.00 to $25.00 and gave the stock an “underweight” rating in a report on Friday, November 10th. Piper Sandler upped their target price on Doximity from $21.00 to $23.00 and gave the company a “neutral” rating in a report on Friday, November 10th. Finally, Bank of America upped their target price on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a report on Tuesday, January 23rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Doximity currently has an average rating of “Hold” and an average target price of $29.64.

View Our Latest Report on DOCS

Doximity Price Performance

Shares of NASDAQ:DOCS opened at $28.54 on Friday. The business’s 50-day moving average is $27.75 and its 200-day moving average is $25.24. Doximity has a 1 year low of $19.71 and a 1 year high of $37.10. The company has a market capitalization of $5.31 billion, a price-to-earnings ratio of 49.21, a P/E/G ratio of 4.58 and a beta of 1.18.

Doximity (NASDAQ:DOCSGet Free Report) last posted its quarterly earnings results on Thursday, November 9th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The business had revenue of $113.61 million for the quarter, compared to the consensus estimate of $109.19 million. Doximity had a return on equity of 14.26% and a net margin of 27.47%. Analysts anticipate that Doximity will post 0.68 EPS for the current year.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction on Friday, November 24th. The stock was sold at an average price of $24.41, for a total value of $61,025.00. Following the sale, the director now owns 10,258 shares in the company, valued at $250,397.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 39.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Doximity

Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Doximity by 5.9% during the third quarter. Vanguard Group Inc. now owns 11,038,475 shares of the company’s stock worth $234,236,000 after purchasing an additional 616,157 shares during the last quarter. BlackRock Inc. lifted its stake in Doximity by 96.0% during the second quarter. BlackRock Inc. now owns 10,688,411 shares of the company’s stock worth $363,620,000 after purchasing an additional 5,235,837 shares during the last quarter. Baillie Gifford & Co. lifted its stake in Doximity by 0.9% during the third quarter. Baillie Gifford & Co. now owns 6,656,242 shares of the company’s stock worth $141,245,000 after purchasing an additional 57,078 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Doximity by 1.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 5,456,068 shares of the company’s stock worth $183,106,000 after purchasing an additional 53,201 shares during the last quarter. Finally, State Street Corp lifted its stake in Doximity by 83.5% during the second quarter. State Street Corp now owns 3,176,208 shares of the company’s stock worth $108,055,000 after purchasing an additional 1,444,979 shares during the last quarter. Institutional investors own 54.65% of the company’s stock.

About Doximity

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.